MACK
Closed
Merrimack Pharmaceuticals Inc
15.13
0.00 (0.00%)
Last Update: 28 May 2024 16:30:00
Yesterday: 15.13
Day's Range: 15.13 - 15.13
Send
sign up or login to leave a comment!
When Written:
12.51
Merrimack Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes innovative medicines for the treatment of cancer. The company was founded in 2000 and is headquartered in Cambridge, Massachusetts. Merrimack's primary focus is on the development of targeted therapies that address specific genetic mutations in cancer cells. The company's lead product is Onivyde, a treatment for pancreatic cancer that has been approved by the U.S. Food and Drug Administration. Merrimack is also developing several other cancer treatments, including MM-121, MM-141, and MM-310. The company has partnerships with several pharmaceutical companies, including Baxter International, Sanofi, and Actavis. Merrimack Pharmaceuticals Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol MACK.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








